CODX
Co-Diagnostics, Inc.
Key Financials
Revenue
$622489
↓ 84.1%
Operating Income
$-50165352
↓ 25.2%
Net Income
$-46895936
↓ 24.6%
Gross Profit
$400112
↓ 86.3%
EPS (Diluted)
$-35.25
↓ 2742.7%
Total Liabilities
$4.1M
↓ 57.5%
Total Assets
$24.7M
↓ 61.3%
Cash & Equivalents
$11.9M
↑ 304.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 6/3/2026 | View on SEC |
| EFFECT | 5/29/2026 | View on SEC |
| S-3 | 5/28/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CODX |
| Company Name | Co-Diagnostics, Inc. |
| CIK | 1692415 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | UT |
| Phone | 8014381036 |